Raymond James & Associates’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.14M | Buy |
169,747
+3,598
| +2% | +$87.7K | ﹤0.01% | 1776 |
|
|
2024
Q2 | $4.18M | Sell |
166,149
-216
| -0.1% | -$5.43K | ﹤0.01% | 1710 |
|
|
2024
Q1 | $4.98M | Sell |
166,365
-24,789
| -13% | -$741K | ﹤0.01% | 1582 |
|
|
2023
Q4 | $6.09M | Sell |
191,154
-5,405
| -3% | -$172K | ﹤0.01% | 1397 |
|
|
2023
Q3 | $6.93M | Buy |
196,559
+2,396
| +1% | +$84.5K | 0.01% | 1261 |
|
|
2023
Q2 | $7.38M | Sell |
194,163
-4,358
| -2% | -$166K | 0.01% | 1238 |
|
|
2023
Q1 | $7.5M | Buy |
198,521
+7,498
| +4% | +$283K | 0.01% | 1204 |
|
|
2022
Q4 | $8.1M | Sell |
191,023
-24,132
| -11% | -$1.02M | 0.01% | 1117 |
|
|
2022
Q3 | $6.91M | Sell |
215,155
-33,703
| -14% | -$1.08M | 0.01% | 1166 |
|
|
2022
Q2 | $8.09M | Buy |
248,858
+43,043
| +21% | +$1.4M | 0.01% | 1092 |
|
|
2022
Q1 | $7.45M | Buy |
205,815
+34,384
| +20% | +$1.24M | 0.01% | 1238 |
|
|
2021
Q4 | $6.78M | Buy |
171,431
+7,102
| +4% | +$281K | 0.01% | 1336 |
|
|
2021
Q3 | $7.18M | Buy |
164,329
+9,867
| +6% | +$431K | 0.01% | 1265 |
|
|
2021
Q2 | $6.31M | Buy |
154,462
+70,219
| +83% | +$2.87M | 0.01% | 1339 |
|
|
2021
Q1 | $2.77M | Sell |
84,243
-6,290
| -7% | -$207K | ﹤0.01% | 1803 |
|
|
2020
Q4 | $3.68M | Buy |
90,533
+12,002
| +15% | +$488K | ﹤0.01% | 1507 |
|
|
2020
Q3 | $2.88M | Buy |
78,531
+3,081
| +4% | +$113K | ﹤0.01% | 1535 |
|
|
2020
Q2 | $2.56M | Sell |
75,450
-48,064
| -39% | -$1.63M | ﹤0.01% | 1572 |
|
|
2020
Q1 | $2.62M | Buy |
123,514
+3,730
| +3% | +$79K | ﹤0.01% | 1427 |
|
|
2019
Q4 | $2.68M | Buy |
119,784
+8,233
| +7% | +$184K | ﹤0.01% | 1648 |
|
|
2019
Q3 | $2.26M | Buy |
+111,551
| New | +$2.26M | ﹤0.01% | 1705 |
|